Skip to main content
. 2021 Sep 15;13(9):10459–10468.

Table 1.

Clinical characteristics of the two groups

Observation group (n = 66) Control group (n = 58) t/x2 P value
Age (Y) 7.5 ± 2.2 7.2 ± 1.8 0.824 0.412
Course of disease (Y) 3.5 ± 1.2 3.6 ± 1.3 0.445 0.657
First onset time of epilepsy (Y) 2.7 ± 0.8 2.4 ± 0.7 1.472 0.145
Sex 0.115 0.735
    Male 39 (59.09) 36 (62.07)
    Female 27 (40.91) 22 (37.93)
BMI (kg/m2) 17.14 ± 0.62 16.96 ± 0.58 1.662 0.099
Place of residence 2.297 0.130
    Urban area 47 (72.71) 48 (82.76)
    Rural area 19 (28.79) 10 (17.24)
Seizure type 0.645 0.724
    Partial seizure 35 (53.03) 32 (55.17)
    Generalized seizure 21 (31.82) 20 (34.48)
    Unclassified seizure 10 (15.15) 6 (10.35)
Family history of epilepsy 0.403 0.526
    Yes 8 (12.12) 5 (8.62)
    No 58 (87.88) 53 (91.38)
Perinatal brain injury 0.229 0.632
    Yes 19 (28.79) 19 (32.76)
    No 47 (71.21) 39 (67.24)
Seizure manifestation 0.618 0.996
    Generalized tonic-clonic seizure 11 (16.67) 9 (15.52)
    Absence seizure 9 (13.63) 10 (17.24)
    Tonic seizure 12 (18.18) 9 (15.52)
    Myoclonic seizure 13 (19.70) 10 (17.24)
    Infantile spasm 9 (13.64) 8 (13.80)
    Atonic seizure 6 (9.09) 6 (10.34)
    Secondarily generalized seizure 6 (9.09) 6 (10.34)